Detalhe da pesquisa
1.
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.
Nature
; 545(7652): 60-65, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28397821
2.
Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health system.
J Thromb Thrombolysis
; 46(1): 1-6, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611105
3.
Central venous stenosis is more often symptomatic in hemodialysis patients with grafts compared with fistulas.
J Vasc Interv Radiol
; 26(2): 240-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25534637
4.
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial.
Nat Cancer
; 5(3): 517-531, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38216766
5.
RNA fusion transcript panel identifies diverse repertoire of fusions in adult glioma patients with therapeutic implications.
Neurooncol Pract
; 10(4): 370-380, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37457221
6.
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement.
Clin Cancer Res
; 28(4): 594-602, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561269
7.
Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival.
Bone Marrow Transplant
; 55(6): 1161-1168, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31992847
8.
An unusual case of metastatic diffuse midline glioma in an adult.
J Neuropathol Exp Neurol
; 82(7): 659-663, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075315
9.
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.
Lung Cancer
; 106: 1-7, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28285682
10.
Immune subgroups and the tumor microenvironment as a potential new biomarker to assess response to immunotherapy.
Chin Clin Oncol
; 8(S1): S24, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31500434